---
document_datetime: 2023-09-21 17:30:50
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tacforius-epar-all-authorised-presentations_en.pdf
document_name: tacforius-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.3937213
conversion_datetime: 2025-12-26 17:15:10.426689
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form             | Route of Administration   | Immediate Packaging    | Pack size                    |
|------------------|-------------------|------------|---------------------------------|---------------------------|------------------------|------------------------------|
| EU/1/17/1244/001 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 30 capsules                  |
| EU/1/17/1244/002 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 30 x 1 capsules (unit dose)  |
| EU/1/17/1244/003 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 50 capsules                  |
| EU/1/17/1244/004 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 50 x 1 capsules (unit dose)  |
| EU/1/17/1244/005 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 100 capsules                 |
| EU/1/17/1244/006 | Tacforius         | 0.5 mg     | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/alu) | 100 x 1 capsules (unit dose) |
| EU/1/17/1244/007 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 capsules                  |
| EU/1/17/1244/008 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 x 1 capsules (unit dose)  |
| EU/1/17/1244/009 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 capsules                  |
| EU/1/17/1244/010 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 x 1 capsules (unit dose)  |
| EU/1/17/1244/011 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 60 capsules                  |
| EU/1/17/1244/012 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 60 x 1 capsules (unit dose)  |
| EU/1/17/1244/013 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 capsules                 |
| EU/1/17/1244/014 | Tacforius         | 1 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 x 1 capsules (unit dose) |
| EU/1/17/1244/015 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 capsules                  |
| EU/1/17/1244/016 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 x 1 capsules (unit dose)  |
| EU/1/17/1244/017 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 capsules                  |
| EU/1/17/1244/018 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 x 1 capsules (unit dose)  |
| EU/1/17/1244/019 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 capsules                 |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form             | Route of Administration   | Immediate Packaging    | Pack size                    |
|------------------|-------------------|------------|---------------------------------|---------------------------|------------------------|------------------------------|
| EU/1/17/1244/020 | Tacforius         | 3 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 x 1 capsules (unit dose) |
| EU/1/17/1244/021 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 capsules                  |
| EU/1/17/1244/022 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 30 x 1 capsules (unit dose)  |
| EU/1/17/1244/023 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 capsules                  |
| EU/1/17/1244/024 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 50 x 1 capsules (unit dose)  |
| EU/1/17/1244/025 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 capsules                 |
| EU/1/17/1244/026 | Tacforius         | 5 mg       | Prolonged-release capsule, hard | Oral use                  | blister (PVC/PVDC/Alu) | 100 x 1 capsules (unit dose) |